KOBAYASHI PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,543 JPY | -0.66% |
|
+0.71% | -18.37% |
| Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
| Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
| Sales 2024 * | 185B 1.17B | Sales 2025 * | 193B 1.22B | Capitalization | 411B 2.6B |
|---|---|---|---|---|---|
| Net income 2024 * | 21.36B 135M | Net income 2025 * | 22.03B 139M | EV / Sales 2024 * | 1.75 x |
| Net cash position 2024 * | 86.04B 543M | Net cash position 2025 * | 93.53B 590M | EV / Sales 2025 * | 1.65 x |
| P/E ratio 2024 * |
19.4
x | P/E ratio 2025 * |
18.7
x | Employees | 3,534 |
| Yield 2024 * |
1.86% | Yield 2025 * |
1.89% | Free-Float | 59.84% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -0.66% | ||
| 1 week | +0.71% | ||
| Current month | +8.79% | ||
| 1 month | +9.35% | ||
| 3 months | -18.53% | ||
| 6 months | -10.21% | ||
| Current year | -18.37% |
1 week
5 496.00
5 716.00
1 month
4 817.005 774.00
Current year
4 700.006 866.00
1 year
4 700.008 530.00
3 years
4 700.0010 470.00
5 years
4 700.0013 120.00
10 years
3 045.0013 120.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chairman | 84 | 62-02-28 | |
Noriaki Hirao
DFI | Director of Finance/CFO | - | - |
| President | 52 | 98-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Haruo Tsuji
BRD | Director/Board Member | 91 | 08-05-31 |
| President | 52 | 98-02-28 | |
| Chairman | 84 | 62-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.19% | 8 M€ | +5.80% | ||
| 0.21% | 15 M€ | +14.10% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 5,543 | -0.66% | 990,600 |
| 24-04-25 | 5,580 | -0.61% | 817,500 |
| 24-04-24 | 5,614 | -1.13% | 1,215,700 |
| 24-04-23 | 5,678 | -0.32% | 1,168,300 |
| 24-04-22 | 5,696 | +3.49% | 1,719,500 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am EDT
More quotes
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Sector
Personal Products
Calendar
2024-05-09
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
5,543
JPY
Average target price
8,182
JPY
Spread / Average Target
+47.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.37% | 2.61B | |
| +10.07% | 381B | |
| +14.18% | 74.67B | |
| -16.59% | 62.59B | |
| +0.82% | 52.86B | |
| -12.40% | 36.11B | |
| +3.54% | 33.57B | |
| +7.92% | 17.29B | |
| +6.30% | 14.75B | |
| -8.65% | 10.82B |
- Stock Market
- Equities
- 4967 Stock
